Champions Oncology Inc Stock
€5.70
Your prediction
Pros and Cons of Champions Oncology Inc in the next few years
Pros
Cons
Performance of Champions Oncology Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Champions Oncology Inc | - | 0.885% | 7.547% | 50.794% | 19.748% | -17.986% | -26.923% |
| Krystal Biotech | -1.300% | 6.816% | 12.262% | 10.726% | 14.290% | 124.452% | - |
| Ardelyx Inc. | -0.150% | 21.417% | 14.691% | -1.070% | 4.250% | 251.726% | 15.639% |
| Evolus Inc | 5.220% | -7.692% | -0.917% | -63.758% | -48.571% | -28.000% | 90.007% |
News
3 Dividend Champion Stocks I'm Watching in 2025
If you are looking for high-yield stocks in a stock market that is hovering near all-time highs, a good place to start your search is with reliable dividend payers.
Dividend Champions fit the bill
Keep an Eye on These 3 Dividend Champion Stocks in 2025
A streak lasting decades is noteworthy. Whether it's a silver wedding anniversary, a quarter century of work, or The Simpsons' 37-year run, these show stability and success.
You can find examples in
7 Best Dividend Champions to Buy Now
Dividend Champions are long-term winners. These companies have grown their dividends for at least 25 straight years. They don't have to be members of the S&P 500 (SNPINDEX: ^GSPC), which broadens


